7th Jul 2006 16:55
Celsis International PLC07 July 2006 CELSIS INTERNATIONAL PLC ANNUAL INFORMATION UPDATE 7 July 2006: Celsis International plc, the rapid diagnostics and analyticalservices company, is pleased to provide an annual information update, inaccordance with the requirements of the Prospectus Rule 5.2. This update refersto information that has been published or made available by the Company to thepublic over the twelve months ended 7 July 2006. 1. Announcements made via a Regulatory Information Service The following regulatory announcements have been made by the Company via aRegulatory Information Service during the previous 12 months. Date of Publication Regulatory Headline 16 June 2006 Doc re: Acquisition14 June 2006 Acquisition14 June 2006 Final Results6 June 2006 Notice of Results28 March 2006 Trading Statement10 March 2006 Treasury Stock7 March 2006 Holding(s) in Company7 March 2006 Holding(s) in Company3 February 2006 New Contracts1 February 2006 Holding(s) in Company30 January 2006 Holding(s) in Company14 November 2005 Change of Adviser9 November 2005 Holding(s) in Company8 November 2005 Interim Results5 October 2005 Notice of Results29 September 2005 Trading Statement22 September 2005 Treasury Stock22 September 2005 Re Agreement21 September 2005 Director/PDMR Shareholding30 August 2005 Share Consolidation24 August 2005 Blocklisting Interim Review4 August 2005 Director/PDMR Shareholding26 July 2005 Result of AGM26 July 2005 AGM Statement18 July 2005 Dividend Declaration11 July 2005 Holding(s) in Company Details of all regulatory announcements for the Company can be found on theLondon Stock Exchange website at: www.londonstockexchange.com 2. Documents filed with Companies House The following documents have been filed by the Company with the Registrar ofCompanies at Companies House during the previous 12 months. Date Document type Description 22 June 2006 403a Declaration of mortgage/charge14 September 2005 288c Change in Director and secretary's particulars23 August 2005 AA Report & accounts01 August 2005 288c Change in Director's particulars11 July 2005 363s Returns Copies of documents filed at Companies House can be obtained from CompaniesHouse, Crown Way, Cardiff, CF14 3UZ or if you are a registered user, throughCompanies House Direct at www.direct.companieshouse.gov.uk. 3. Documents filed with the Financial Services Authority The following documents have been filed by the Company with the FinancialServices Authority and/or sent to shareholders during the previous 12 months. Date Description 3 July 2006 2006 Annual Report and Accounts3 July 2006 Circular for Company Share Option Plan14 June 2006 Circular for the Proposed Acquisition of In Vitro Technologies Inc Copies of the above documents may be viewed at the UK Listing Authority'sDocument Viewing Facility at 25 the North Colonnade, Canary Wharf, London E145HS. Enquiries: Celsis International plc Tel: 01638 600 151Jay LeCoque, Chief Executive OfficerJenny Parsons, Corporate Communications Financial Dynamics Tel: 020 7831 3113Ben AtwellAnna Keeble Notes to editors Celsis International plc Celsis International plc is a rapid diagnostics and analytical services company. The company is listed on the London Stock Exchange (CEL.L). Using proprietary technology, the Product Group is the world leader in theprovision of diagnostic systems for the rapid detection of microbialcontamination. It works in close collaboration with many of the world's leadingpharmaceutical, personal care and beverage companies, ensuring the safety andquality of products bound for consumers. The Laboratory Group providesoutsourced analytical testing services to pharmaceutical and biopharmaceuticalcompanies to ensure the stability and chemical composition of their products. In addition to ensuring product quality and safety for consumers, both divisionshave the capacity to deliver substantial cost savings to Celsis' customers. Byreducing the time it takes to test and release raw materials and finished goodsto the market place, Celsis' products facilitate increased manufacturingproductivity and improved supply chain management. Further information can be found on its website at www.celsis.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Celadon Pharmaceuticals